Drug-Resistant Malaria: The Era of ACT
- PMID: 21308525
- PMCID: PMC3058555
- DOI: 10.1007/s11908-010-0099-y
Drug-Resistant Malaria: The Era of ACT
Abstract
As drug-resistant falciparum malaria has continued to evolve and spread worldwide, artemisinin-based combination therapies (ACT) have become the centerpiece of global malaria control over the past decade. This review discusses how advances in antimalarial drug resistance monitoring and rational use of the array of ACTs now available can maximize the impact of this highly efficacious therapy, even as resistance to artemisinins is emerging in Southeast Asia.
Conflict of interest statement
Figures
References
-
- Trape JF. The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg. 2001;64:127. - PubMed
-
- World Health Organization. Methods for Surveillance of Antimalarial Drug Efficacy. Geneva: World Health Organization; 2009.
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
